Clinical Trial Update: Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating CD4 cell count changes after replacing tenofovir disoproxil fumarate with abacavir, or replacing didanosine + TDF with abacavir + lamiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Didanosine (didanosine)
• Lamivudine (lamivudine)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)
• abacavir (abacavir)

Snippet

Sponsor: Hospital de Granollers | Conditions: HIV Infections | Phase 3 | Status: COMPLETED